Medications
FDA approves first injection regimen for HIV prevention
(HealthDay)—The first injection drug to prevent HIV infection was approved by the U.S. Food and Drug Administration on Monday.
Dec 21, 2021
0
25
Hiv Infection
HIV & AIDS
Changes in the brain hinder addiction recovery in people who are HIV-positive
Researchers with the Del Monte Institute for Neuroscience at the University of Rochester are studying how the brain puts the 'brakes' on behavior. That may be different in individuals recovering from cocaine addiction and ...
Dec 21, 2021
0
18
HIV & AIDS
Why addressing racism against Black women in health care is key to ending the US HIV epidemic
Forty years into the HIV/AIDS epidemic, Black women continue to bear the highest burden of HIV among women.
Dec 7, 2021
0
7
Medications
Use of HIV prevention treatments is very low among Southern Black gay men
Use of antiretroviral treatments to prevent HIV infection—called pre-exposure prophylaxis or PrEP—is very low among high-risk populations with poor access to HIV care, especially Black men in the South who have sex with ...
Dec 3, 2021
0
8
HIV & AIDS
New therapeutic target for HIV identified
Scientists in Montreal and London have identified the key role played by transcription factor RORC2 in HIV infection: the molecule attaches itself to parts of the virus's genome yet doesn't prevent it from replicating.
Dec 1, 2021
0
23
HIV & AIDS
Landmark study points to source of rapid aging, chronic inflammation in people living with HIV
In a groundbreaking study of people living with HIV, University of Alberta researchers found that elusive white blood cells called neutrophils play a role in impaired T cell functions and counts, as well as the associated ...
Nov 9, 2021
0
82
HIV & AIDS
Oral health in HIV+ population
Pushpa Pandiyan, associate professor of biological sciences in the School of Dental Medicine, and a team of researchers have been working to discover the cause behind residual systemic inflammation and dysfunction of the ...
Nov 5, 2021
0
12
Medications
Awareness of, referral to HIV PrEP low among Hispanics
(HealthDay)—About one in four Hispanic persons tested for HIV are aware of preexposure prophylaxis (PrEP) and about one in five of those eligible for referral are referred to PrEP providers, according to research published ...
Oct 8, 2021
0
2
Vaccination
Who's eligible for Pfizer booster shots in US?
Millions of Americans are now eligible to receive a Pfizer booster shot to help increase their protection against the worst effects of the coronavirus.
Sep 24, 2021
0
4
HIV & AIDS
Fewer than one in 20 people living with HIV in England expected to be unaware of status by 2025
England is on track to have diagnosed 95% of people living with HIV by 2025, putting it in a strong position to eliminate HIV transmission by 2030, say researchers at the MRC Biostatistics Unit, University of Cambridge, and ...
Sep 23, 2021
0
12
